MCAP.ST
HoldFallen FavouriteMedCap AB (publ) · Healthcare · Sweden · $816M
SEK 513.50 +0.3% · close 7 Oct · scored 9 Oct
Fallen Favourite: A good business, still expensive, and the price is falling.
Read our full research report on MCAP.ST (Jul 2026), freeDoes StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT MEDCAP AB (PUBL)
Read
MedCap AB (publ) is a diversified healthcare company that acquires and develops specialized medical technology and life science companies, spanning diagnostics, medical devices, and specialized pharmaceuticals. MedCap's competitive advantage lies in its decentralized business model, allowing acquired companies to retain entrepreneurial drive while benefiting from strategic guidance and financial resources. It operates as a niche consolidator, building a robust portfolio in specialized healthcare segments.
FINANCIAL SUMMARY (SEK)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.6B | 1.8B | 2.1B | 23.8% | 2.3B | 2.4B | 2.7B | 12.9% |
| EPS (SEK) | 7.90 | 11.60 | 14.00 | 14.70 | 23.0% | 16.08 | 20.33 | 24.50 | 29.1% |
| Shares | 14.8M | 14.8M | 15.0M | 15.0M | +1.4% | 15.0M | — | — | — |
| Debt | 340.0M | 261.3M | 358.0M | 482.9M | 12.4% | 456.7M | — | — | — |
| Equity | 856.3M | 1.0B | 1.3B | 1.5B | 19.2% | — | — | — | — |
| Op CF | 85.5M | 228.0M | 360.0M | 342.7M | 58.8% | 386.6M | — | — | — |
| Inv CF | -56.1M | -152.3M | -128.8M | -391.3M | — | — | — | — | — |
| Fin CF | 61.2M | -119.7M | -46.1M | 52.2M | — | — | — | — | — |
Calmer than 63% of stocks we rank over the past year (35% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MCAP.ST are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MCAP.ST | MedCap AB (publ)(you) | $816M | 65 | Hold |
| EKTA-B.ST | Elekta AB (publ) | $2.0B | 69 | Buy |
| NOLA-B.ST | Nolato AB (publ) | $1.5B | 75 | Buy |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $775M | 38 | Hold |
| VITR.ST | Vitrolife AB (publ) | $1.3B | 43 | Hold |
| CEVI.ST | CellaVision AB (publ) | $404M | 82 | Strong Buy |
| BICO.ST | BICO Group AB (publ) | $160M | 56 | Hold |
| SECT-B.ST | Sectra AB (publ) | $5.4B | 58 | Hold |
| PAX.ST | Paxman AB (publ) | $143M | 53 | Hold |
| CRAD-B.ST | C-Rad AB (publ) | $112M | 86 | Strong Buy |
Peer medians: ROE 4.1% · P/E 33.9x · Gross margin 66.5%
Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.